Latest filing published 22 Aug 2017 for Niagen Bioscience, Inc., €1.7M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +35.9%Entry US$3.26 · Close at T+365 US$4.43
- -2.1%Entry US$3.29 · Close at T+365 US$3.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Pioneer Step Holdings Ltd: trading record in brief
All filings by Pioneer Step Holdings Ltd on record concern Niagen Bioscience, Inc. The record holds 2 filings, for trades running from 24 May 2017 to 18 August 2017.
No open-market sale appears; the market trades are 2 purchases worth €7.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 22 August 2017, reports an open-market purchase of €1.7M in Niagen Bioscience, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Pioneer Step Holdings Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 786,167 shares@ US$2.6023.0% of flowCommon StockSEC:0000899243-17-020793:0Canonical exit: 16 Nov 2017 (T+90)
- 2,521,526 shares@ US$2.6077.0% of flowCommon StockSEC:0000899243-17-014475:0Canonical exit: 22 Aug 2017 (T+90)
2 of 2 declarations
